Sorrel Medical

About

Q&A

When was Sorrel Medical acquired and by whom?

Sorrel Medical was acquired in June 2023 by LTS Lohmann Therapie-System for $110,000,000.

What is Sorrel Medical's primary business?

Sorrel Medical develops and manufactures wearable drug-delivery devices designed to optimize the patient experience and value for pharmaceutical companies. Their platform is intended for subcutaneous delivery of injectable drugs, biologics, and biosimilars.

What was a significant strategic partnership for Sorrel Medical in 2020?

In September 2020, Sorrel Medical signed a strategic partnership agreement with a leading pharmaceutical company to integrate their drugs into Sorrel's wearable patch-pumps, with the most advanced integrated products potentially reaching the market by the end of 2021.

What expansion did Sorrel Medical undertake in July 2020?

In July 2020, Sorrel Medical opened a new manufacturing facility with state-of-the-art cleanroom facilities to increase production capacity for its wearable drug delivery devices and support global pharmaceutical partners.

How many employees did Sorrel Medical have at the time of its acquisition?

Sorrel Medical had 11-50 employees at the time of its acquisition.

What award did Sorrel Medical receive in June 2019?

In June 2019, Sorrel Medical's wearable drug delivery platform won the Best New Technology Solution in Drug Delivery designation from MedTech Breakthrough.

What was the impact of the acquisition by LTS Lohmann Therapie-System on Eitan Medical?

The acquisition of Sorrel by LTS Lohmann Therapie-System in June 2023 allowed Eitan Medical, Sorrel's parent company, to strengthen its business and focus on its core infusion therapy portfolio.

Sectors & technology

Highlights

Tags